Turmoil at the FDA Threatens Biotech Recovery Unexpected delays, infighting and a staffing crisis are fueling investors’ unease. Post navigation Previous Previous post: People Are Hooked on AI Videos That Turn Politicians Into BabiesNext Next post: The Math Legend Who Just Left Academia—for an AI Startup Run by a 24-Year-Old Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Related News Samsung’s first open-ear earbuds, Galaxy Buds On, arrive with Gemini Live 0 Snap-On Dropped A Limited Edition Pumpkin Carving Kit – Here’s What’s Included 0